SCHEMBL18859533

SCHEMBL18859533

c1ccc2c(c1)sc1c3ccccc3c(-c3ccc(-c4cc(-n5c6ccccc6c6ccccc65)cc(-n5c6ccccc6c6ccccc65)c4)cc3)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 2/20 0.36
▸ TNKS2 Q9H2K2 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HRH4 Q9H3N8 2/20 0.33
▸ LIMK1 P53667 3/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ KRAS P01116 1/20 0.31
▸ PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18859544 0.94 KDM4E (0.36) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL18859548 0.91 KDM4E (0.35) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL18859551 0.90 KDM4E (0.40) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL18859531 0.87 KDM4E (0.40) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL22274214 0.87 KDM4E (0.35) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL24281036 0.85 ATM (0.35) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL24280290 0.84 ATM (0.38) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL24280537 0.83 MEN1 (0.33) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL24280521 0.82 KMT2A (0.36) TNKSTNKS2KDM4EATML3MBTL1
SCHEMBL24280519 0.82 KMT2A (0.36) TNKSTNKS2KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885KDM4E 3298/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885KDM4E 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback